Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
GLP-1 medications influence hunger signals and insulin production, which helps regulate appetite and blood sugar levels
In another report, a 26week treatment with the GLP1R/GIPR dual agonist LY3298176 (Tirzepatide, Eli Lilly), showed significant reduction in A1c in an incremental, dosedependent manner (4 doses from 1 mg to 15 mg, A1c reduction from 1.06% to 1.94% respectively)
Compound details
The FDA has approved it for weight management, but it's intended as part of a comprehensive weight loss strategy involving diet and exercise, not a standalone solution
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
